Clinical Trial: Lyme Borreliosis and Early Cutaneous Diagnostic

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Lyme Borreliosis and Early Cutaneous Diagnostic

Brief Summary:

Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients included are those with the early skin manifestation (erythema migrans).

This new proteomic method will be compared to the two existing method: culture of Borrelia and PCR detection of Borrelia (DNA detection of the bacteria).


Detailed Summary:
Sponsor: University Hospital, Strasbourg, France

Current Primary Outcome: Compare the sensitivity (percentage of positive tests) of the SRM / MS-MS to techniques of PCR and culture Borrelia [ Time Frame: One year study ]

percentage of positive tests with all three techniques (SRM/MS-MS ; PCR ; culture)


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital, Strasbourg, France

Dates:
Date Received: April 8, 2015
Date Started: August 2015
Date Completion: August 2016
Last Updated: August 6, 2015
Last Verified: April 2015